IXICO (LON:IXI) Shares Up 11.1% – Time to Buy?

IXICO plc (LON:IXI) rose 11.1% during mid-day trading on Wednesday . The stock traded as high as GBX 8.98 ($0.12) and last traded at GBX 8.75 ($0.12). Approximately 119,069 shares traded hands during trading, an increase of 283% from the average daily volume of 31,090 shares. The stock had previously closed at GBX 7.88 ($0.10).

IXICO Trading Up 9.3 %

The company has a debt-to-equity ratio of 3.32, a current ratio of 2.85 and a quick ratio of 4.90. The company has a 50-day moving average of GBX 9.36 and a 200 day moving average of GBX 10.34. The company has a market cap of £8.71 million, a PE ratio of -2.44, a price-to-earnings-growth ratio of -0.38 and a beta of 0.86.

IXICO Company Profile

IXICO is a fast growing and profitable medical data analytics company, providing data management and advanced analytics to the pharmaceutical clinical trials market. Established in 2004 and listed as a public company in October 2013, IXICO has firmly established itself as a trusted partner to the global pharmaceutical industry developing new therapies for neurological conditions such as Alzheimer’s, Parkinson’s and Huntington’s disease.

Our purpose is to advance medicine and human health by turning data into clinically meaningful information, providing valuable new insights in neuroscience.